**5. Conclusions**

In our investigation, among the many neurological cases potentially attributable to infectious agents, about 27% were confirmed as a zoonosis, but there remain many cases of inflammation not classified and potentially constituting a health risk. The results of this research show that animals can be an important reservoir for agents of neurozoonoses; therefore, monitoring of neurological diseases of animals should be designed to reduce the number of infections in humans and may be a good model for the study of therapeutic strategies in cases of infection. Neurozoonosis monitoring in animals may also allow for the surveillance of possible emerging or re-emerging infectious agents.

From available literature data it is clear that the population segments most affected by zoonoses are children, the elderly and the immunocompromised, particularly those with AIDS and chemotherapy or transplant recipients. The best way to protect these at-risk groups is through prevention, which can only be done through a national surveillance network. Further studies should also aim to identify the pathogenesis and the possible etiologic agents of idiopathic inflammatory disease or those of "unknown aetiology" to exclude the likelihood of potentially zoonotic agents.
